Genomics and Proteomics Tools Market in South Korea - 2022 Edition

Region:Asia

Author(s):

Product Code:GMR46914

Download Sample Report download
Buy the Full ReportStarting from $2200
Published on

March 2022

Total pages

74

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $2200

About the Report

About the Report

Genomics provides an overview of the complete set of genetic instructions provided by the DNA, while proteomics studies dynamic protein products and their interactions. Genetics and genomics both play roles in health and disease. The genomics and proteomics tools market in South Korea was estimated at USD 833 million in 2021 and is expected to hit USD 1,634 million by 2028, registering a CAGR of 10.1% from 2022 to 2028 as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into genomics and proteomics tools market in South Korea. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the genomics and proteomics tools industry.

This industry report offers market estimates and forecasts of the South Korea market, followed by a detailed analysis of the product, and technology. The South Korea market for genomics and proteomics tools can be segmented by product: instruments, reagents and consumables, software. The reagents and consumables segment captured the largest share of the market in 2021. Genomics and proteomics tools market is further segmented by technology: PCR, flow cytometry, mass spectrometry, NGS sequencing, nucleic acid purification, nucleic acid separation, others.

By product:

- instruments

- reagents and consumables

- software

By technology:

- PCR

- flow cytometry

- mass spectrometry

- NGS sequencing

- nucleic acid purification

- nucleic acid separation

- others

The report also provides a detailed analysis of several leading genomics and proteomics tools market vendors that include Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Hitachi High-Tech Corporation, Illumina, Inc., Merck KGaA, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

- To analyze and forecast the market size of the genomics and proteomics tools market in South Korea.

- To classify and forecast the genomics and proteomics tools market in South Korea based on product, technology.

- To identify drivers and challenges for the genomics and proteomics tools market in South Korea.

- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the genomics and proteomics tools market in South Korea.

- To identify and analyze the profile of leading players operating in the genomics and proteomics tools market in South Korea.

Why Choose This Report

- Gain a reliable outlook of the genomics and proteomics tools market in South Korea forecasts from 2022 to 2028 across scenarios.

- Identify growth segments for investment.

- Stay ahead of competitors through company profiles and market data.

- The market estimate for ease of analysis across scenarios in Excel format.

- Strategy consulting and research support for three months.

- Print authentication provided for the single-user license.

Products

Products

Genomics and Proteomics Tools, South Korea,


Companies

Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Hitachi High-Tech Corporation, Illumina Inc., Merck KGaA, Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc.

Table of Contents

Table of Contents

TABLE OF CONTENTS

FIGURES AND TABLES

PART 1. INTRODUCTION

- Report description

- Objectives of the study

- Market segment

- Years considered for the report

- Currency

- Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

- Introduction

- Drivers

- Restraints

- Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

- Instruments

- Reagents and consumables

- Software

PART 6. MARKET BREAKDOWN BY TECHNOLOGY

- PCR

- Flow cytometry

- Mass spectrometry

- NGS sequencing

- Nucleic acid purification

- Nucleic acid separation

- Others

PART 7. KEY COMPANIES

- Abbott Laboratories

- Agilent Technologies, Inc.

- Bio-Rad Laboratories, Inc.

- Bruker Corporation

- Danaher Corporation

- F. Hoffmann-La Roche AG

- GE Healthcare

- Hitachi High-Tech Corporation

- Illumina, Inc.

- Merck KGaA

- Pacific Biosciences of California, Inc.

- PerkinElmer, Inc.

- QIAGEN N.V.

- Shimadzu Corporation

- Takara Bio Inc.

- Thermo Fisher Scientific Inc.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022